Last reviewed · How we verify
Phase II Study: Evaluate Efficacy of Iocide Oral Rinse in a Human Clinical Trial of Gingival Inflammation and Investigate Effects on Biological Markers Indicative of Systemic Disease
The purpose of this study is to explore the efficacy of Iocide oral rinse in a human clinical trial of gingivitis. Iocide oral rinse will be evaluated against a placebo rinse. Indices for gingivitis, plaque and bleeding will be scored and blood tests will be performed to determine the effect of the antimicrobial oral rinse on relative levels of biological markers of inflammation.
Details
| Lead sponsor | Biomedical Development Corporation |
|---|---|
| Phase | Phase 2 |
| Status | UNKNOWN |
| Enrolment | 76 |
| Start date | 2013-02 |
| Completion | 2014-05 |
Conditions
- Gingivitis
- Investigation of Biological Markers of Inflammation
Interventions
- Iocide Oral Rinse
- Placebo
Primary outcomes
- Change in Mean Gingival Index (GI) — Study Days -21 to -7 through Study Day 168
Countries
United States